Abstract |
Canonical Wnt signaling has been implicated in the regulation of multiple myeloma (MM) growth. Here, we investigated whether the targeting of this pathway with a novel pharmacological inhibitor ICG-001 would result in an anti- tumor effect and improvement of chemosensitivity in MM. As expected, ICG-001 specifically down-regulated β- catenin/TCF-mediated transcription in MM cells. Treatment with ICG-001 resulted in growth arrest and apoptosis in MM cell lines and primary MM cells. Moreover, ICG-001 enhanced the cytotoxic effects of doxorubicin and melphalan and abrogated chemoresistance of MM cells to these chemotherapeutics induced by bone marrow stroma. The cytotoxic effect of ICG-001 was caspase-dependent and mediated through transcriptional up-regulation of BH3-only pro-apoptotic members of the Bcl-2 family Noxa and Puma but not through inhibition of canonical Wnt signaling. ICG-001 selectively induced apoptosis in primary MM cells but did not affect non-MM cells of the bone marrow microenvironment. Experiments using a xenograft model of MM showed substantial anti- tumor effects of this compound in vivo. Thus, our study demonstrated that the small molecule inhibitor ICG-001 has strong anti-MM effects and could be developed further for therapeutic intervention in this disease.
|
Authors | Eileen R Grigson, Maria Ozerova, Alexandra Pisklakova, Hao Liu, Daniel M Sullivan, Yulia Nefedova |
Journal | PloS one
(PLoS One)
Vol. 10
Issue 1
Pg. e0117693
( 2015)
ISSN: 1932-6203 [Electronic] United States |
PMID | 25635944
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Bridged Bicyclo Compounds, Heterocyclic
- ICG 001
- Pyrimidinones
- Wnt Proteins
|
Topics |
- Animals
- Bone Marrow Cells
(drug effects, metabolism)
- Bridged Bicyclo Compounds, Heterocyclic
(pharmacology)
- Cell Death
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- Humans
- Mice
- Multiple Myeloma
(pathology)
- Pyrimidinones
(pharmacology)
- Stromal Cells
(drug effects, metabolism)
- Tumor Burden
(drug effects)
- Wnt Proteins
(metabolism)
- Wnt Signaling Pathway
(drug effects)
- Xenograft Model Antitumor Assays
|